In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not
- PMID: 30452561
- DOI: 10.7326/ACPJC-2018-169-10-054
In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not
Comment on
-
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26. Lancet. 2018. PMID: 30057104 Free PMC article. Clinical Trial.